ConductScience.org, home

Paper28705809

The oncogenic role of the spliced somatostatin receptor sst5TMD4 variant in prostate cancer.

Hormaechea-Agulla D and 15 others. FASEB J, 2017. Cited by 42 papers, by iCite.

Cite this record

ConductScience Library. The oncogenic role of the spliced somatostatin receptor sst5TMD4 variant in prostate cancer. Papers, record 28705809. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28705809

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The oncogenic role of the spliced somatostatin receptor sst5TMD4 variant in prostate cancer.
PubMed
Journal
FASEB J
PubMed
Year
2017
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
42
iCite
Relative citation ratio, by iCite
1.58
iCite
Revised in PubMed
2018-12-02
PubMed

Authors16

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hormaechea-Agulla DDaniel
2Jiménez-Vacas JMJuan M
3Gómez-Gómez EEnrique
4L-López FFernando
5Carrasco-Valiente JJulia
6Valero-Rosa JJosé
7Moreno MMMaría M
8Sánchez-Sánchez RRafael
9Ortega-Salas RRosa
10Gracia-Navarro FFrancisco
11Culler MDMichael D
12Ibáñez-Costa AAlejandro
13Gahete MDManuel D
14Requena MJMaría J
15Castaño JPJusto P
16Luque RMRaúl M

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alternative SplicingMajor topic
Gene Expression Regulation, NeoplasticMajor topic
MAP Kinase Signaling SystemMajor topic
Oncogene ProteinsMajor topic
Prostatic NeoplasmsMajor topic
Receptors, SomatostatinMajor topic
Wnt Signaling PathwayMajor topic
Aged
Animals
Cell Line, Tumor
Heterografts
Humans
Male
Mice
Mice, Inbred BALB C
Mice, Nude
Middle Aged
Neoplasm Metastasis
Neoplasm Transplantation

Source PubMed

Download CSV of topics

Cited by31

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.

PMIDTitleJournalYearIn PapersSource
42941869G Protein-Coupled Receptors in Prostate Cancer: Pathophysiological Implications and Potential for Innovative Therapeutics.Int J Mol Sci2026https://conductscience.org/library/papers/42941869PubMed
42135849Periprostatic adipose tissue-derived adipokine profile in prostate cancer patients reveals two distinct molecular phenotypes linked to obesity-related comorbidities: multifaceted role of lipocalin-2.Cell Commun Signal2026https://conductscience.org/library/papers/42135849PubMed
41012572Daunomycin Nanocarriers with High Therapeutic Payload for the Treatment of Childhood Leukemia.Pharmaceutics2025https://conductscience.org/library/papers/41012572PubMed
39758250Clinical value of circulating splicing factors in prostate cancer: SRRM1 as a novel predictive biomarker and therapeutic target.Mol Ther Oncol2024https://conductscience.org/library/papers/39758250PubMed
39356765SRSF6 modulates histone-chaperone HIRA splicing to orchestrate AR and E2F activity in prostate cancer.Sci Adv2024https://conductscience.org/library/papers/39356765PubMed
39232176The Exon Junction Complex component EIF4A3 plays a splicing-linked oncogenic role in pancreatic ductal adenocarcinoma.Cancer Gene Ther2024https://conductscience.org/library/papers/39232176PubMed
38203605Somatostatin and Somatostatin Receptors in Tumour Biology.Int J Mol Sci2023https://conductscience.org/library/papers/38203605PubMed
38187140Altered CELF4 splicing factor enhances pancreatic neuroendocrine tumors aggressiveness influencing mTOR and everolimus response.Mol Ther Nucleic Acids2024https://conductscience.org/library/papers/38187140PubMed
36555216Gold Nanosystems Covered with Doxorubicin/DNA Complexes: A Therapeutic Target for Prostate and Liver Cancer.Int J Mol Sci2022https://conductscience.org/library/papers/36555216PubMed
36418657The uprise of RNA biology in neuroendocrine neoplasms: altered splicing and RNA species unveil translational opportunities.Rev Endocr Metab Disord2023https://conductscience.org/library/papers/36418657PubMed
36361790Somatostatin, Cortistatin and Their Receptors Exert Antitumor Actions in Androgen-Independent Prostate Cancer Cells: Critical Role of Endogenous Cortistatin.Int J Mol Sci2022https://conductscience.org/library/papers/36361790PubMed
35282415Dysregulation of the miRNome unveils a crosstalk between obesity and prostate cancer: miR-107 asa personalized diagnostic and therapeutic tool.Mol Ther Nucleic Acids2022https://conductscience.org/library/papers/35282415PubMed
35163067Somatostatin Receptor Splicing Variant sst5TMD4 Overexpression in Glioblastoma Is Associated with Poor Survival, Increased Aggressiveness Features, and Somatostatin Analogs Resistance.Int J Mol Sci2022https://conductscience.org/library/papers/35163067PubMed
35086552SF3B1 inhibition disrupts malignancy and prolongs survival in glioblastoma patients through BCL2L1 splicing and mTOR/ß-catenin pathways imbalances.J Exp Clin Cancer Res2022https://conductscience.org/library/papers/35086552PubMed
35008278Sarcopenia and Ghrelin System in the Clinical Outcome and Prognosis of Gastroenteropancreatic Neuroendocrine Neoplasms.Cancers (Basel)2021https://conductscience.org/library/papers/35008278PubMed
34653618Prostate cancer: Alternatively spliced mRNA transcripts in tumor progression and their uses as therapeutic targets.Int J Biochem Cell Biol2021https://conductscience.org/library/papers/34653618PubMed
34638313Molecular and Clinical Implications of Somatostatin Receptor Profile and Somatostatin Analogues Treatment in Oral Cavity Squamous Cell Carcinoma.Cancers (Basel)2021https://conductscience.org/library/papers/34638313PubMed
34572980Comparative Cytotoxic Activity of Hydroxytyrosol and Its Semisynthetic Lipophilic Derivatives in Prostate Cancer Cells.Antioxidants (Basel)2021https://conductscience.org/library/papers/34572980PubMed
33948343Prostate cancer racial, socioeconomic, geographic disparities: targeting the genomic landscape and splicing events in search for diagnostic, prognostic and therapeutic targets.Am J Cancer Res2021https://conductscience.org/library/papers/33948343PubMed
33141183Splicing machinery dysregulation drives glioblastoma development/aggressiveness: oncogenic role of SRSF3.Brain2020https://conductscience.org/library/papers/33141183PubMed

See all 31 cited byDownload CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
EPHB22048PubTator's text mininghttps://conductscience.org/library/genes/2048NCBI Gene
MAPK85599PubTator's text mininghttps://conductscience.org/library/genes/5599NCBI Gene
MYC4609PubTator's text mininghttps://conductscience.org/library/genes/4609NCBI Gene
RB15925PubTator's text mininghttps://conductscience.org/library/genes/5925NCBI Gene
SST6750PubTator's text mininghttps://conductscience.org/library/genes/6750NCBI Gene
SSTR56755PubTator's text mininghttps://conductscience.org/library/genes/6755NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28705809

GET https://conductscience.org/api/papers/v1/28705809/cited_by?page=2